New research shows that weight loss medications can stop the progression of prediabetes. Experts don’t all agree on such a ...

Nuvectis Pharma reports mixed Phase 1b results for NXP800 in ovarian cancer, showing antitumor activity and improved safety with adjusted dosing.

Intercept’s US president Vivek Devaraj said the pharma company still believes in the evidence supporting the liver disease ...

Recently, Penny’s Jeffersontown-based company, 2 Cents Inc., announced that it would be launching a ready-to-drink (RTD) ...

Ovintiv strengthens its Montney shale portfolio with Paramount Resources acquisition, expects increased free cash flow and ...

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

Gabriele Sorbara, an analyst from Siebert Williams Shank & Co, reiterated the Buy rating on Ovintiv (OVV – Research Report). The ...

Jason Gerberry, an analyst from Bank of America Securities, reiterated the Buy rating on Liquidia Technologies (LQDA – Research Report).

Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different look: New rules require drugmakers to be clearer and more direct when ...

The IDE will allow the medtech giant to conduct clinical trials at US sites with the robotic surgical system called Ottava.

The U.S. FDA has granted orphan drug designation to Eisai's (OTCPK:ESALF) Lenvima (lenvatinib) for esophageal cancer. The ...